Long-term effects of NK-104 (itavastatin), a new HMG-CoA reductase inhibitor, in patients with heterozygous familial hypercholesterolemia
Keyword(s):
1998 ◽
Vol 20
(3)
◽
pp. 539-548
◽
2001 ◽
Vol 39
(05)
◽
pp. 199-204
◽
2004 ◽
Vol 35
(5)
◽
pp. 257-262